Medical Condition News

RSS

Electromagnetic radiation from cellular phones may affect bone strength

Electromagnetic radiation from cellular phones may adversely affect bone strength, suggests a study in the March Journal of Craniofacial Surgery. The journal is published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health.

25 Mar 2011

U.S. statewide bank crises study finds no major impact of depression on mortality

A study published today provides a new perspective on the Great Depression of the 1930s. A widely held view is that there were remarkable improvements in life expectancy of over five years.

25 Mar 2011

Dabigatran etexilate is less costly, more effective for stroke treatment in patients with AF

A new economic analysis, published online in Thrombosis and Haemostasis, suggested that Boehringer Ingelheim's novel oral direct thrombin inhibitor dabigatran etexilate is cost-effective compared to current treatment options, particularly in real-world clinical practice.

25 Mar 2011

SARcode's SAR 1118 Phase 2 data against dry eye to be presented at ARVO meeting

SARcode Corporation announced today that clinical data for their lead compound, SAR 1118, has been accepted for presentation during the upcoming Association for Research in Vision and Ophthalmology Annual Meeting being held May 1–May 5, 2011, in Fort Lauderdale, Florida.

25 Mar 2011

FDA approves Boston Scientific's Clik Anchor for Precision Plus Spinal Cord Stimulator System

Boston Scientific Corporation today announced U.S. Food and Drug Administration (FDA) approval and U.S. launch of the Clik™ Anchor for its Precision Plus™ Spinal Cord Stimulator (SCS) System, the world's first rechargeable SCS device for chronic pain management. The Clik Anchor features an innovative locking system designed to improve lead anchoring speed and consistency.

25 Mar 2011

Stemedica begins allogeneic mesenchymal stem cell Phase I/II trial in patients with ischemic stroke

Stemedica Cell Technologies, Inc., a leader in adult allogeneic stem cell manufacturing, research and development, announced today that its specially formulated ischemic adult allogeneic mesenchymal stem cells have been successfully used to treat the first patient in an ischemic stroke study conducted at the University of California, San Diego.

25 Mar 2011

New discovery on fat metabolism in worms can lead to novel obesity treatment

Researchers exploring human metabolism at the University of California, San Francisco have uncovered a handful of chemical compounds that regulate fat storage in worms, offering a new tool for understanding obesity and finding future treatments for diseases associated with obesity.

25 Mar 2011

UC Berkeley, UCSF partner to help develop neural prostheses for brain repair

Neuroscientists and engineers at UCSF and UC Berkeley have joined forces to help pioneer a new frontier of brain repair - the development of devices that would allow patients with such conditions as stroke, spinal cord injury, traumatic brain injury and Lou Gehrig's disease to control prosthetics through thoughts alone.

25 Mar 2011

DMC launches new procedure to protect diabetic patients with PAD from leg amputations

The Detroit Medical Center Cardiovascular Institute has implemented a ground-breaking new medical technology designed to protect patients with diabetes-related arterial disease from the risk of foot or leg amputation.

25 Mar 2011

Positive top-line results from Targacept's TC-5619 Phase 2 trial in adults with ADHD

Targacept, Inc today announced top-line results from a Phase 2 proof of concept trial of TC-5619 as a treatment for adults with attention deficit/hyperactivity disorder.

25 Mar 2011

VisualSonics introduces Vevo LAZR system to advance cancer research

VisualSonics Inc., a leader in real-time, in vivo, high-resolution micro-imaging systems and a wholly-owned subsidiary of SonoSite Inc., today announced the launch of the Vevo LAZR Photoacoustics Imaging system for the advancement of cancer research in the pre-clinical imaging market.

25 Mar 2011

Study finds risk of heart attack among patients with TIA

Patients who have suffered a "mini stroke" are at twice the risk of heart attack than the general population, according to research reported in Stroke: Journal of the American Heart Association.

25 Mar 2011

Brand Surgical Institute offers diabetic patients with life changing weight loss procedure

Millions of individuals all over the country suffer from obesity, preventing them from living an active lifestyle, as well as causing a number of health conditions, such as heart disease, diabetes, and high blood pressure.

25 Mar 2011

Columbia University, Sanofi-aventis collaborate to develop innovative diabetes medicines

Sanofi-aventis announced today a research collaboration with Columbia University Medical Center for the development of innovative diabetes medicines.

25 Mar 2011

USPTO issues Notice of Allowance to AlphaRx ARX8203 pain product candidate

AlphaRx Inc. has received a Notice of Allowance from the United States Patent and Trademark Office for its lead pain product candidate code named ARX8203, a potentially safer drug intended for pain treatment.

25 Mar 2011

Study: Surgeon enthusiasm linked to high spinal procedure rates

Surgeons in some areas are more likely to recommend surgery for low back problems—and those differences in "surgeon enthusiasm" are a major factor driving regional variations in spinal surgery rates, suggests a study in the March 14 issue of Spine. The journal is published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health.

25 Mar 2011

Quantum dots allow stem cell therapy monitoring for brain injury

A new technique using "quantum dots" produced through nanotechnology is a promising approach to monitoring the effects of stem cell therapies for stroke and other types of brain damage, reports the April issue of Neurosurgery, official journal of the Congress of Neurological Surgeons.

25 Mar 2011

Positive top-line results from POZEN's PA32540 Phase 1 study against cardiovascular disease

POZEN Inc., a pharmaceutical company committed to transforming medicine that transforms lives, announced today positive top-line results of a Phase 1 study of PA32540, a novel coordinated-delivery tablet of enteric-coated aspirin and immediate-release omeprazole.

25 Mar 2011

Researchers identify gene that can predict hypersensitivity to epilepsy drug

Research published this week in the New England Journal of Medicine. A multinational team of scientists led by the Royal College of Surgeons in Ireland and the University of Liverpool has identified a gene that could indicate if epilepsy patients starting a common drug treatment are likely to experience side-effects ranging from a mild skin irritation to the potentially fatal Steven-Johnson Syndrome.

25 Mar 2011

APC-300 drug significantly inhibits pancreatic cancer cell growth: Adamis

Adamis Pharmaceuticals Corporation announced today that in addition to its activity in prostate cancer, its drug APC-300 significantly inhibits the growth of pancreatic cancer cells.

25 Mar 2011

Medical Condition News

Electromagnetic radiation from cellular phones may affect bone strength

U.S. statewide bank crises study finds no major impact of depression on mortality

Dabigatran etexilate is less costly, more effective for stroke treatment in patients with AF

SARcode's SAR 1118 Phase 2 data against dry eye to be presented at ARVO meeting

FDA approves Boston Scientific's Clik Anchor for Precision Plus Spinal Cord Stimulator System

Stemedica begins allogeneic mesenchymal stem cell Phase I/II trial in patients with ischemic stroke

New discovery on fat metabolism in worms can lead to novel obesity treatment

UC Berkeley, UCSF partner to help develop neural prostheses for brain repair

DMC launches new procedure to protect diabetic patients with PAD from leg amputations

Positive top-line results from Targacept's TC-5619 Phase 2 trial in adults with ADHD

VisualSonics introduces Vevo LAZR system to advance cancer research

Study finds risk of heart attack among patients with TIA

Brand Surgical Institute offers diabetic patients with life changing weight loss procedure

Columbia University, Sanofi-aventis collaborate to develop innovative diabetes medicines

USPTO issues Notice of Allowance to AlphaRx ARX8203 pain product candidate

Study: Surgeon enthusiasm linked to high spinal procedure rates

Quantum dots allow stem cell therapy monitoring for brain injury

Positive top-line results from POZEN's PA32540 Phase 1 study against cardiovascular disease

Researchers identify gene that can predict hypersensitivity to epilepsy drug

APC-300 drug significantly inhibits pancreatic cancer cell growth: Adamis

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News